Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy-Reference-Cited by-同舟云学术

Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy

Published:2022-03 Issue: Volume:168 Page:234-240
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Møller Ditte Sloth,Lutz Christina Maria,Khalil Azza Ahmed,Alber Markus,Holt Marianne Ingerslev,Kandi Maria,Schmidt Hjørdis Hjalting,Tvilum Marie,Appelt Ane,Knap Marianne Marquard,Hoffmann Lone

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference27 articles.

1. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy;Khalil;Acta Oncol,2015

2. The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial);van Diessen;Radiother Oncol.,2019

3. A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60 Gy and 66 Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC;Hansen;Radiother Oncol,2017

4. Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study;De Ruysscher;Radiother Oncol,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy;Radiotherapy and Oncology;2024-11

2. Progressive auto-segmentation for cone-beam computed tomography-based online adaptive radiotherapy;Physics and Imaging in Radiation Oncology;2024-07

3. Online Adaptive Radiotherapy in Pelvic and Thoracic Cancers - Comparing Toxicities, Clinical Outcomes and Technical Parameters between Conventional Image-Guided Radiotherapy and Online Adaptive Radiotherapy – The Study Protocol for the Prospective, Registry-Based, Phase II Trial (PRoART);2024-06-20

4. Deformable anthropomorphic pelvis phantom for dose accumulation verification;Physics in Medicine & Biology;2024-06-11

5. Are offline ART decisions for NSCLC impacted by the type of dose calculation algorithm?;Technical Innovations & Patient Support in Radiation Oncology;2024-03